Prostate Cancer Death and Radiation Therapy
Rate of increase in PSA value Prior to diagnosis of Prostate Cancer predicts risk of death following Radiation Therapy.
|
Prostate Cancer Death
Clinical factors can help determine risk of prostate cancer death following 'biochemical' cancer recurrence after radical prostatectomy.
|
Lifestyle and Diet May Stop or Reverse Prostate Cancer Progression
Men with early stage prostate cancer who make intensive changes in diet and lifestyle may stop or perhaps even reverse the progression of their illness, according to a new study.
|
Change Your Diet To Cut Risk of Prostate Cancer
In Canada, prostate cancer is the most common cancer threat to men.
|
Combination Hormone/Vaccine Therapy for Prostate Cancer May Benefit Patients Whose Disease Returns
Study finds that a cancer vaccine combined with hormone deprivation therapy can help patients with recurrence of prostate cancer.
|
Enlarged Prostate Drug Allows for Less Invasive Prostate Biopsies
A drug that is currently used to treat an enlarged prostate may improve the accuracy of prostate biopsies, a pilot study shows.
|
Early Prostate Cancer Screening May Reduce Mortality Rate by 35%
Early screening of prostate cancer in asymptomatic men may reduce their risk of death from metastatic prostate cancer by as much as 35 per cent.
|
Presence OF High-Risk Prostate Cancer Can Be Predicted Without A Biopsy
Identifying high risk prostate cancer means more prudent treatment decisions, fewer unnecessary biopsies.
|
Vitamin D, Taxotere Combination Promising For Advanced Prostate Cancer
The study determines if this combination should be developed as a treatment for advanced prostate cancer.
|
Imaging Tool Helps Locate Sites of Early Recurrent Prostate Cancer
A diagnostic scan may help localize recurrent prostate disease in men who have had surgical removal of the prostate and show early signs of recurrence.
|
Prostate Cancer Study Affirms Value of PSA Test
PSA remains a vital tool for determining risk of recurrence in prostate cancer patients.
|
"Silenced" Gene Suggests Greater Risk and a Possible Diagnostic Marker for African-Americans with Prostate Cancer
Among African Americans with prostate cancer, a tumor suppressing gene called GSTP1 is inactivated at a rate 3.5 times higher than among Caucasians.
|
Exposure to Sunlight May Decrease Risk of Prostate Cancer, Study Finds
Prostate cancer risk my be decreased by increased exposure to sunlight because the body manufactures the active form of vitamin D from exposure to sunlight.
|
Non Invasive Prostate Cancer Treatment with Sonablate(R) 500 Approved in Canada
According to the Prostate Cancer Research Foundation of Canada, at least one in every seven Canadian men is expected to develop the disease in their lifetime.
|
Physicians Develop Test for Success of Common Prostate Cancer Treatment
Prostate cancer patients who reach a very low level PSA (prostate specific antigen) after combined radiation treatment have a 99 percent chance of survival free from disease.
|
Keep Dad in the Game: Nutrition and Prostate Cancer Guide
New Nutrition and Prostate Cancer Guide Issued by the Prostate Cancer Foundation for Father's Day.
|
Discovery of Gene Offers Promising Potential in Prostate Cancer Diagnosis
This discovery provides an to a select group of genes, whose expression is frequently altered in prostate cancer cells and have potential to improve diagnosis, prognosis or therapy of prostate cancer in the future.
|
Flaxseed Rich Diet Blocks Prostate Cancer Growth and Development in Mice
The study shows the benefits of flaxseed in reducing the growth and development of prostate cancer.
|
Marriage or Relationship Are Good for Prostate Cancer Treatment
Men with spouses, partners fare better after treatment for prostate cancer than single men, UCLA study finds
|
New Prostate Cancer Treatment Uses Innovative Technology
Unique Radiation Treatment Designed by Stanford to Fight Prostate Cancer.
|
Inherited Gene May Increase Risk for Prostate Cancer by 50%
Results Point to Novel Pathway for Development of Prostate Cancer. Prostate cancer is among the most prevalent cancers worldwide and is the second leading cause of male cancer related death in the United States.
|
New Test For Early Detection Of Prostate Cancer Shows Promise
EPCA or early prostate cancer antigen, can successfully detect prostate cancer in its earliest stages.
|
UCLA Cancer Researchers Shake Loose A "Hidden" Biomarker in Prostate Cancer Cells
Discovery May Pave Way for Immunotherapy Treatments for Prostate Cancer.
|
Steroids Worsen Prostate Cancer Severity
Steroids Add 'Fuel to the Fire' When it Comes to Prostate Cancer
|
Increasing Prostate Cancer Testing Could Lead to Comprehensive Health Screenings for Men
Prostate testing rates need to increase dramatically to save the 30,000 men who die each year from prostate cancer.
|
African American Men 2.5 Times More Likely to Die from Prostate Cancer
Prostate cancer continues to increase its death grip on African American men as about 1,000 black men are expected to die this year from the disease.
|
Combination Radiation/Vaccine Therapy for Prostate Cancer May Benefit Some Patients
A pilot study of an experimental therapy for prostate cancer has found that a cancer vaccine can be safely administered to patients undergoing radiation therapy.
|
Earlier Use of Prostate Cancer Vaccines Urged By Hopkins Scientists
Timing is everything when it comes to killing prostate cancer cells with specially tailored vaccines. Most prostate cancer vaccines currently are tested on men whose cancers are growing and no longer responsive to hormone therapy.
|
Prostate Cancer: What Every Man Should Know
The vast majority of men with prostate cancer will survive the disease and enjoy a high quality of life after treatment. Prostate cancer is the most common cancer in men.
|
Early Trial Indicates Prostate Cancer Vaccine Increases Immunity and Reduces Tumor Cells
A prostate cancer vaccine that trains a patient's own dendritic cells to attack a protein antigen expressed by tumors can robustly boost a patient's immune system.
|
Men More Likely to Get Screened for Prostate Cancer Than Colon Cancer,
Prostate screens could be 'teachable moment' to encourage colon checks. What men do pay attention to is prostate cancer. And that has researchers thinking an annual prostate cancer screening might be a good opportunity to urge men to be screened for colon cancer too.
|
Some Men with Low PSAs Have Prostate Cancer: Most Cancers Found Are Not Likely to Be Clinically Significant
Men with low PSA (prostate specific antigen) levels on screening tests can still have prostate cancer. In this study, prostate cancers were detected by biopsy in men with normal PSA levels.
|
Prostate Cancer - North American men more at risk than their Eastern counterparts
Research indicates that prostate cancer is significantly lower in Asia than in North America. In fact, less than two percent of Asian men are diagnosed with prostate cancer.
|
Prostate Cancer: What to watch for
Risk factors for developing prostate cancer include being 65 years of age or older, and a family history of the disease. Symptoms of prostate cancer include the following.
|
New Prostate Cancer Treatment Helps Prolong Life
A promising new prostate cancer treatment not only provides quality of life benefits, but also offers a survival advantage for men whose cancer has metastasized, or spread to other parts of the body.
|
Natural Help For An Enlarged Prostate
It is important to take care of your prostate and address any prostate, be it an enlarged prostate, prostetitis (inflammation of the prostate) or prostate cancer early on. Take an active role and protect yourself by having your prostate checked regularly.
|
Prostate Ultrasound and Biopsy
Prostate ultrasound and biopsy is performed to evaluate abnormal results of a digital rectal exam or an elevated prostate-specific antigen (PSA). Prostate ultrasound is a procedure in which a probe about the size of a finger is inserted a short distance into the rectum.
|
Combination of Cancer Drugs Increases Survival Rate of Some Prostate Cancer Patients: New Research Shows
Prostate cancer patients whose cancer has spread to other parts of the body and who no longer respond to hormone therapy may benefit from a combination of the cancer drugs docetaxel and estramustine, according to a new study published in the Oct. 8 issue of the New England Journal of Medicine.
|
Should I be concerned if close relatives are diagnosed with Prostate Cancer?
Having a close relative with prostate cancer is considered a risk factor for developing it yourself. In fact, hereditary prostate cancer accounts for 10 to 15 per cent of all cases and tends to develop at a relatively early age (before the age of 55). An individual who has two first-degree relatives (father and brother) with prostate cancer may be up to eight times more at risk of developing prostate cancer in his lifetime than a man with no family history.
|
Preventing prostate cancer - what you can do
Prostate cancer is the number one cancer threat to the lives and health of men. It is the most common cancer, and the second most deadly after lung cancer. An increasing number of men are expected to develop the disease in their lifetime, with 19,000 being diagnosed every year.
|
